One of the main obstacles encountered when trying to culture human seminoma (SE) 
Besides proliferation and differentiation, apoptosis (programmed cell death) is one of the main mechanisms controlling cell fate during embryogenesis, morphogenesis and tissue homeostasis (Hinchcliffe, 1981; Waring et al., 1991; Williams, 1991; Collins et al., 1994; Vaux et al., 1994) . Recently, Frisch and Francis (1994) reported that epithelial cells undergo apoptosis upon disruption of their interactions with the extracellular matrix, in a process they named anoikis. Apparently, interactions between cells and their matrix, mediated by integrins (the matrix receptors), provide the cells with a survival and/or proliferation signal, which blocks anoikis. Besides specific cell -matrix interactions, growth factor-receptor interactions are also involved in prevention of apoptosis. Many cell types are known to depend upon growth factor or hormonal stimulation to survive (and proliferate): among others, prostate and breast cells on steroids (Kerr and Searle, 1973; Bardon et al., 1987) , vascular endothelial cells on fibroblast growth factor (Araki et al., 1990) , mouse embryo cells on epidermal growth factor (Rawson et al., 1991) and glial cells on platelet-derived growth factor (Barres et al., 1992) . Pesce et al. (1993 Pesce et al. ( , 1994 reported that murine primordial germ cells (PGCs) die apoptotically at extragonadal sites during embryogenesis and during in vitro handling upon isolation from the embryo. This in vitro apoptosis could be blocked by the presence of specific growth factors, i.e. stem cell factor (SCF) or leukaemia inhibitory factor (LIF) (Pesce et al., 1993) . In addition to extracellular factors, several intracellularly acting agents have been implicated in the control of apoptosis. Bcl-2 protein (located in the membrane of mitochondria, nucleus and endoplasmatic reticulum; Jacobson et al., 1993) , was the first oncogene product reported to interfere with apoptosis, sustaining cell survival without increasing proliferation rates in non-Hodgkin's lymphoma (Tsujimoto et al., 1984; Bakshi et al., 1985; Cleary and Sklar, 1985; Vaux et al., 1988; Hockenberry et al., 1990) . Bcl-2 has been reported to block apoptosis upon growth factor withdrawal or disruption of (Hockenberry et al., 1990; Garcia et al., 1992) . In certain cell types, apoptosis cannot be blocked by bcl-2 (over)expression and the death pathway in these cells appears to be bcl-2 independent (Sentman et al., 1991). The nuclear protein p53, which constitutes a checkpoint for DNA integrity during the cell cycle (Oren, 1992) , has recently been implicated in the induction of apoptosis (Donehower et al., 1992; Oren, 1992; Lane, 1993) . Upon DNA damage, p53 expression is enhanced and the damaged cell enters a p53-dependent apoptotic pathway. Removal of certain growth factors can also result in the onset of p53-dependent apoptosis (Yonish-Rouach et al., 1991; Eizenberg et al., 1995) . In several cell types and upon induction by various stimuli, apoptosis can also proceed in a p53-independent way (Clarke et al., 1993; Lowe et al., 1993) .
Primary seminomas (SEs), tumours considered to be the malignant counterparts of PGCs (Holstein et al., 1987; Skakkebxk et al., 1987; Gondos, 1993; Holstein, 1993) , occur at specific locations, i.e. in the gonads (Ulbright and Roth, 1987; Young et al., 1994 ), mediastinum (Dehner, 1990 ) and midline of the brain (Dehner, 1986) . Like murine PGCs, which can become reprogrammed to give rise to pluripotent embryonic germ cells when cultured in the presence of SCF, LIF and basic fibroblast growth factor (Matsui et al., 1992; Resnick et al., 1992) , SE cells express the SCF receptor c-Kit (Strohmeyer et al., 1991; Murty et al., 1992; Olie et al., 1995a) . SE cell survival and proliferation appear to depend upon a very specific microenvironment and growth factor supply. These findings suggest that a lack of apoptosis and a differentiation block could have contributed to tumour formation.
Recently we reported that attempts to culture human SE cells in vitro were hampered by massive degeneration of the tumour cells within the first 3 days of culture (Olie et al., 1995a (Oosterhuis et al., 1989) . Fresh tumour tissue was mechanically dissociated in a suitable volume of medium at room temperature using two crossed scalpel blades. Tissue fragments were allowed to settle in a 15 or 50 ml tube containing 10 or 30 ml of medium respectively. The supernatant contained almost only single cells, as analysed by phase-contrast microscopy using a Zeiss Axiovert microscope. From the supernatant a volume containing at least 2 x 106 cells was fixed at 0°C in 5 ml of 1% formalin (in phospate-buffered saline; PBS) for 30 min. Cells were spun down at 1500 r.p.m. for 5 min and resuspended in 200 ,l of ice-cold PBS. Subsequently, the suspension was mixed with 400 ,ul of ice-cold 96% ethanol. Samples were stored at -20°C until further processing for flow cytometry (FCM). To the remaining fresh single cell suspension 10% (final concentration) dimethylsulphoxide (Merck, Darmstadt, Germany), was added slowly. The suspension was aliquotted, automatically frozen in a Kryo 10 Series 2 (Planer Biomed, Sunbury-on-Thames, UK) (-2°C min-' to -5°C, -1°C min-' to -40°C, -50C min-' to -1600C) and stored under liquid nitrogen.
Lymphocyte depletion Cryopreserved single cell suspensions from 12 SEs, containing SE cells and lymphocytes, were rapidly thawed at 37°C, washed in 10 ml of culture medium and counted. The suspensions were treated with a 2.5-fold excess (relative to the total number of SE cells and lymphocytes) of magnetic beads coated with anti-CD2 monoclonal antibody (Dynal, Skoyen, Norway) to deplete lymphocytes. After 15-20 min incubation at room temperature with gentle shaking, 4 ml of culture medium was added, and the beads were removed using a magnetic particle collector (Dynal). The supernatant, containing enriched SE cells, was removed. The beads were washed twice with culture medium and all supernatants were pooled. Removal of the lymphocytes was verified by microscopic examination of a cytospin preparation with haematoxylin and eosin staining. After treatment with magnetic beads, all suspensions contained less than 15% of lymphocytes. Similar packed-cell volumes from untreated or bead-treated samples were used for DNA extraction.
Detection of DNA breaks and apopotic cells In situ end labelling One of the early events during apoptosis is single-or double-strand DNA cleavage by endogenous endonuclease activity (Wyllie, 1980 (1) three 10 jgm slides from snap-frozen SE blocks; (2) snapfrozen pellets from fresh SE cell suspensions; (3) snap-frozen pellets from either lymphocyte-containing or lymphocytedepleted SE cell suspensions, that had previously been cryopreserved. Cells were lysed in 400 ,l of buffer [10 mM Tris, 400 mM sodium chloride, 2 mM EDTA, 100 ,ug ml-' proteinase K (Boehringer)], overnight at 37°C. The lysate was extracted with 500 jl of phenol-chloroform (1:1) and subsequently with chloroform-isoamylalcohol (24:1). DNA was precipitated by addition of 50 pl of 3 M sodium acetate and 800 p1 of 100% ethanol, and overnight incubation at -20°C. The pellet was spun down, washed with 70% ethanol, vacuum dried, dissolved in 100 jil of TE (10 mM Tris, 0.1 mM EDTA) with 50 mg 1-' RNAase A (Sigma) and incubated at 37°C for 30 min. Subsequently, a 20 ,ul solution was subjected to electrophoresis in a 1.8% agarose gel at 60 V for 2-3 h. cisplatin (Bristol-Myers Squibb, Woerden, The Netherlands) for 2 h. After washes with medium, the cells were incubated for 48 h. Floating cells were harvested by centrifugation of the culture medium at 1000 r.p.m. for 5 min. After addition of 10 ml of fresh culture medium, attached cells were harvested from the flasks using cell scrapers and spun down. Cells from untreated cultures, harvested by scraping, were used as a negative control. All samples were split into two fractions; one was fixed in 4% formalin at room temperature for 1 h and paraffin embedded (for ISEL), the other was fixed in 1% formalin and stored under ethanol (for FCM). Before ISEL or FCM, performed in duplicate, the samples were treated with pronase E for 0 or 30 min at room temperature. Upon ISEL, the percentage of morphologically apoptotic and labelled cells was determined by counting a total of at least 100 cells. In the negative controls a low percentage of labelled cells was detected (not shown). Without pronase treatment ISEL and FCM detected <1% labelled cells. This percentage increased up to 2% when pronase was used before labelling. In the samples of floating cells from treated cultures, application of pronase did not markedly affect the percentage of labelled cells detected with FCM (about 60% either with or without pronase). However, pronase treatment of paraffin sections of these cells was necessary to avoid underestimation of the number of apoptotic cells. With pronase treatment, about 60% of the CHO cells was found to be apoptotic, i.e. similar to the FCM results, while this number was about 40% without pronase. Probably, pronase treatment is necessary to provide full access of DNA polymerase to paraffin-embedded cells. The ISEL and FCM results were confirmed by the presence of DNA ladders only in the cisplatin-treated cultures (not shown).
Based on the above results, paraffin-embedded SE tissue blocks were analysed using 30 min of pronase treatment at room temperature and ISEL, while SE cell suspensions were not pronase treated and analysed by FCM.
Results
In Table I the results on all SE tissue blocks and cell suspensions are summarised. In paraffin-embedded intact tissue from 11 out of 14 SEs less than 4% of the tumour cells had morphological characteristics of apoptosis and DNA strand breaks (Figure la) . In three SEs this number was higher, i.e. 20%, 13% and 15% respectively (Figure lb) . Apoptosis-specific DNA ladders, indicating internucleosomal Figure  2a ). In contrast, these ladders were present in the three SEs with up to 20% apoptotic cells (not shown). All lymphocytedepleted SE cell suspensions (n = 11) obtained after mechan- h ical dissociation showed ladder patterns; for some tumours the ladders were (nearly) absent in the non-lymphocytedepleted suspensions and well visible in the SE cell-enriched suspensions (shown in Figure 2b for TL602, TL614 and TLI187). In non-lymphocyte-depleted cell suspensions up to 85% of the SE cells contained nicked DNA, as detected with FCM (Figure 3 ). In the intact tissues of tumours TL614 and TL4942 a relatively high amount of lymphocytes was present. The cell suspensions of these tumours contained very few SE cells, either viable or apoptotic.
Two tumours (TL6209 and TL6329) underwent additional analysis. From each tumour, three pairs of tissue blocks of approximately 0.125 cm3 were incubated at 4°C and three pairs at 34°C in medium A. At both temperatures, the pairs were incubated for 1, 4, or 16 h respectively. From each pair, one block was fixed in 4% formalin for paraffin embedding, while the other was snap frozen in liquid nitrogen for DNA analysis. Table II and Figure 4 show that in both tumours the apoptotic process was slowed down by keeping the microenvironment intact, while incubation of the cells at 4°C resulted in a further delay in the onset of apoptosis. Staining intensity of labelled SE cells was higher and the cells had a more pronounced apoptotic morphology at 34°C than at 4°C. In addition, on electrophoresis gels, DNA ladders were only detected after incubation at 34°C for 4 and 16 h, indicative of the occurrence of double-stranded DNA cleavage only at this temperature. (Frisch and Francis, 1994) , growth factor withdrawal (Collins et al., 1994) , oxidative stress (Buttke and Sandstrom, 1994) and cytotoxic drugs . We have now shown that SE cell suspensions contain up to 85% apoptotic cells immediately after disruption of the cellular microenvironment, while very few (<3%) apoptotic cells are present in intact SE tissue. The immediate DNA fragmentation appears unique and indicative of the high propensity of SE cells to undergo apoptosis, a characteristic which might be used to eliminate SE in vivo. Induction of apoptosis is probably the basis of the successful treatment of SE patients with radiation and chemotherapy (Giannone and Wolff, 1988; Hanks et al., 1992; Fossa et al., 1995) . Several lines of evidence suggest that the ras oncogene can inhibit the process of apoptosis (Frisch and Francis, 1994; Nooter et al., 1995; Olie et al., 1995b) . Frisch and Francis (1994) reported that cells are (partially) protected against anoikis (apoptosis upon disruption of cell-matrix interactions) by activated ras or overexpression of bcl-2. Schlaepfer et al. (1994) have shown that the integrin-mediated anoikissuppressing activity of the extracellular matrix is most likely signalled by the ras pathway. Using another approach, we recently found that oncogenic ras can inhibit drug-induced apoptosis, in cells transfected with the c-Ha-ras oncogene . Our observation that SEs bearing a mutant ras showed enhanced survival and proliferation in cocultures with embryonal fibroblast feeder layers, as compared with SEs with wild-type ras (Olie et al., 1995a, b) , could be based on the apoptosis/anoikis-abrogating activity of mutant ras. However, the four ras mutant tumours among the SEs analysed here (TL614, TL1049, TL3544, TL8837) (Olie et al., 1995a, b) , were indistinguishable from the non-mutant tumours m the assays performed. The exact relation between the onset of apoptosis upon tumour dissociation, the presence of a mutant ras gene and in vitro behaviour is a subject for further study.
Apoptosis of cultured murine PGCs, which appear to need a specific microenvironment for both in vivo and in vitro survival and proliferation, can be suppressed by SCF (Pesce et al., 1993 The apoptotic process analysed in SE cells appears to be independent of (enhanced) p53 expression, which could not be detected immunohistochemically. In addition, the absence of bcl-2 expression is in concordance with the (high) susceptibility of SE cells to apoptosis. Future analysis of the expression of bcl-2 family members in SE cells should yield more information on the control of apoptosis in these cels.
Blocking the onset of apoptosis appears crucial for successful in vitro culture of SE cells. Once apoptosis can be abrogated, the pathobiological relation between the two histological types of human primary testicular germ cell tumours of adults, namely SEs and non-seminomatous testicular germ cell tumours (for which in vitro culture conditions and cell lines are available) might be studied in vitro.
